Usefulness of ultrasonography for gout.

PubWeight™: 1.57‹?› | Rank: Top 4%

🔗 View Article (PMID 22386965)

Published in Joint Bone Spine on March 03, 2012

Authors

Sébastien Ottaviani1, Thomas Bardin, Pascal Richette

Author Affiliations

1: UFR Médicale, Service De Rhumatologie, Université Paris-7, Hôpital Bichat, AP-HP, 46 rue Henri-Huchard, 75018 Paris, France. sebastien.ottaviani@bch.aphp.fr

Articles by these authors

Gout. Lancet (2009) 4.33

New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis Rheum (2005) 2.48

Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Ann Rheum Dis (2012) 1.95

Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates. Arthritis Rheum (2004) 1.89

Splint for base-of-thumb osteoarthritis: a randomized trial. Ann Intern Med (2009) 1.86

Gout: why is this curable disease so seldom cured? Ann Rheum Dis (2012) 1.84

Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis. J Rheumatol (2004) 1.83

Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: evidence for genetic heterogeneity. Arthritis Rheum (2002) 1.81

Contribution of clinical tests to the diagnosis of rotator cuff disease: a systematic literature review. Joint Bone Spine (2008) 1.65

Unité Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren's disease-specific disability. Arthritis Care Res (Hoboken) (2011) 1.50

Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents. Expert Opin Drug Deliv (2012) 1.46

The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. Joint Bone Spine (2011) 1.41

Efficacy of joint lavage in knee osteoarthritis: meta-analysis of randomized controlled studies. Rheumatology (Oxford) (2009) 1.40

Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci U S A (2007) 1.29

Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis. Ann Rheum Dis (2010) 1.27

An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease. Rheumatology (Oxford) (2009) 1.24

Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis. Arthritis Res Ther (2006) 1.22

Sodium thiosulphate treatment of uraemic tumoral calcinosis. Rheumatology (Oxford) (2013) 1.21

Muscle involvement in sarcoidosis: a retrospective and followup studies. J Rheumatol (2006) 1.21

Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study. J Rheumatol (2007) 1.18

Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey. Health Qual Life Outcomes (2012) 1.13

Estrogens, cartilage, and osteoarthritis. Joint Bone Spine (2003) 1.13

The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study. Arthritis Res Ther (2007) 1.12

Hypomagnesemia associated with chondrocalcinosis: a cross-sectional study. Arthritis Rheum (2007) 1.10

Developing a provisional definition of flare in patients with established gout. Arthritis Rheum (2012) 1.10

Biologic agents in osteoarthritis: hopes and disappointments. Nat Rev Rheumatol (2013) 1.07

Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele. Arthritis Res Ther (2005) 1.06

Achondroplasia: from genotype to phenotype. Joint Bone Spine (2007) 1.06

Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens (2015) 1.05

Ultrasonography in gout: a case-control study. Clin Exp Rheumatol (2012) 1.03

IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis. Ann Rheum Dis (2006) 1.03

Severe gouty arthritis and mild neurologic symptoms due to F199C, a newly identified variant of the hypoxanthine guanine phosphoribosyltransferase. Arthritis Rheum (2009) 1.02

Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae. J Rheumatol (2002) 1.02

Psoriasis induced by anti-tumor necrosis factor therapy: a class effect? J Rheumatol (2007) 1.00

Genetics of Dupuytren's disease. Joint Bone Spine (2011) 0.98

Cyclic tensile stretch modulates proteoglycan production by intervertebral disc annulus fibrosus cells through production of nitrite oxide. J Cell Biochem (2003) 0.97

TNF alpha antagonist therapy and safety monitoring. Joint Bone Spine (2011) 0.96

Peroxisome proliferator-activated receptor-gamma down-regulates chondrocyte matrix metalloproteinase-1 via a novel composite element. J Biol Chem (2004) 0.96

Paget's disease of bone in the French population: novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlations. J Bone Miner Res (2007) 0.95

Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departments. J Rheumatol (2008) 0.95

International position paper on febuxostat. Clin Rheumatol (2010) 0.95

The ANKH gene and familial calcium pyrophosphate dihydrate deposition disease. Joint Bone Spine (2004) 0.95

Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol (2014) 0.94

Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry. Ann Rheum Dis (2012) 0.93

Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective study. J Orthop Res (2011) 0.92

Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy. Arthritis Res Ther (2011) 0.92

A high interleukin 1 receptor antagonist/IL-1beta ratio occurs naturally in knee osteoarthritis. J Rheumatol (2008) 0.92

The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype. Ann Rheum Dis (2010) 0.92

Association of the X-chromosomal genes TIMP1 and IL9R with rheumatoid arthritis. J Rheumatol (2009) 0.91

Prevalence and distribution of autoimmune diseases in 368 rheumatoid arthritis families. J Rheumatol (2008) 0.91

Testing for the association of the KIAA1109/Tenr/IL2/IL21 gene region with rheumatoid arthritis in a European family-based study. Arthritis Res Ther (2009) 0.90

Premature enthusiasm for the use of methotrexate for refractory chondrocalcinosis: comment on the article by Chollet-Janin et al. Arthritis Rheum (2008) 0.90

Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes. Arthritis Rheum (2006) 0.90

Therapeutic perspectives on uricases for gout. Joint Bone Spine (2012) 0.88

Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases. Arthritis Res Ther (2013) 0.88

Musculoskeletal complications of hereditary hemochromatosis: a case-control study. J Rheumatol (2010) 0.88

An exploratory ultrasound study of early gout. Clin Exp Rheumatol (2011) 0.88

Prevalence of generalized osteoarthritis in a population with knee osteoarthritis. Joint Bone Spine (2010) 0.87

Prognostic value of early computed tomography in radiculopathy due to lumbar intervertebral disk herniation. A prospective study. Joint Bone Spine (2003) 0.87

How to define responders in osteoarthritis. Curr Med Res Opin (2013) 0.86

Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol. Nat Clin Pract Rheumatol (2006) 0.85

Assessment of dynamic humeral centering in shoulder pain with impingement syndrome: a randomised clinical trial. Ann Rheum Dis (2011) 0.85

Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis. Joint Bone Spine (2012) 0.85

Paradoxical adverse effects of anti-TNF-alpha treatment: onset or exacerbation of cutaneous disorders. Expert Rev Clin Immunol (2009) 0.84

Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis. Drugs Aging (2015) 0.84

[Basic calcium phosphate crystal deposition disease]. Presse Med (2011) 0.83

Structure-modifying agents for osteoarthritis: an update. Joint Bone Spine (2004) 0.83

Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA. Curr Med Res Opin (2010) 0.82

Needle aponeurotomy in Dupuytren's disease. Joint Bone Spine (2011) 0.82

Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis. Arthritis Rheum (2008) 0.82

The TNFRSF1A R92Q mutation is frequent in rheumatoid arthritis but shows no evidence for association or linkage with the disease. Ann Rheum Dis (2007) 0.82

Muscle magnetic resonance imaging sensitivity does not decrease in chronic, mild, or proximal lower limb neuropathies. Muscle Nerve (2012) 0.81

Purine-rich foods: an innocent bystander of gout attacks? Ann Rheum Dis (2012) 0.81

A TNFR1 genotype with a protective role in familial rheumatoid arthritis. Arthritis Rheum (2004) 0.81

Septic arthritis of the hip with psoas abscess caused by Non-typhi Salmonella infection in an immunocompetent patient. Joint Bone Spine (2007) 0.81

Hypomagnesemia and chondrocalcinosis in short bowel syndrome. J Rheumatol (2005) 0.81

Anterior chest wall pain in recent inflammatory back pain suggestive of spondyloarthritis. data from the DESIR cohort. J Rheumatol (2013) 0.80

Multi-needle aponeurotomy for advanced Dupuytren's disease: preliminary results of safety and efficacy (MNA 1 study). Joint Bone Spine (2011) 0.80

Colchicine for the treatment of gout. Expert Opin Pharmacother (2010) 0.80

Interleukin-1 receptor antagonist in refractory haemochromatosis-related arthritis of the hands. Ann Rheum Dis (2013) 0.80

Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registry. Arthritis Care Res (Hoboken) (2014) 0.79

[New therapeutic options for gout]. Presse Med (2011) 0.79

Nephrogenic systemic fibrosis. Curr Opin Rheumatol (2010) 0.79

Efficacy of a functional restoration program for chronic low back pain: prospective 1-year study. Joint Bone Spine (2010) 0.79

Effect of music on anxiety and pain during joint lavage for knee osteoarthritis. Clin Rheumatol (2011) 0.79

Back pain in a patient with Wegener's granulomatosis. J Rheumatol (2008) 0.79